Pharmaceuticals
-
Good results for new ovarian cancer surveillance approach
The use of a new algorithm for ovarian cancer surveillance in women at raised genetic risk can help delay preventive surgery, researchers report today. Read more
-
Early hope for halting cancer-causing gene
Promising results have been reported in the first trial to effectively inhibit a gene known to cause cancer, a European conference has heard. Read more
-
Exposure to anaesthesia in the womb appears safe
New research indicates that the foetus’ brain development is not at risk if pregnant women undergo anaesthesia. Read more
-
Scientists tackle disease resistance to new cancer drug
British cancer researchers believe they might be able to ensure a “promising” new stomach cancer drug class is used in a way that outsmarts the disease’s ability to develop resistance. Read more
-
Neurostimulation may improve swallowing difficulties
Neurostimulation could improve ability to swallow in patients affected by conditions such as stroke, according to a new UK study. Read more
-
Breakthrough in motor neurone disease treatment
A new drug for motor neurone disease has yielded “notable” results in a phase 3 trial, British researchers have reported. Read more
-
VTE risk for obese women who take combined pill
The combined birth control pill is linked to a 24-fold increased risk of venous thromboembolism (VTE) in obese women compared with women who are not obese, researchers say today. Read more
-
Newborn biomarker shows early eczema risk
A new biomarker indicates whether a baby is at a risk of developing eczema within the first two years of life, a conference is to hear today. Read more
-
Polypill shows promise after infarction
A polypill has successfully been used to provide drug treatments after adverse cardiovascular events, a conference has heard. Read more
-
Statin users should ‘continue’ with the therapy
Stopping statin treatment early could substantially reduce lifetime protection against heart disease because most of the benefit occurs late in life, a major conference is to hear. Read more
